AstraZeneca Loses Bid To Nix Toprol Antitrust Suits
By Allison Grande ( April 14, 2010, 5:58 PM EDT) -- AstraZeneca Pharmaceuticals LP has lost its bid to toss a pair of consolidated class action complaints filed by Toprol-XL direct purchasers and end-payors accusing the pharmaceutical giant of trying to block generic versions of its blockbuster heart drug through sham patent infringement litigation....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.